HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 22, No 06, June 2018 – Cancer - Therapies and strategies for better patient outcomes       » Gardasil 9 supply running short in Hong Kong       » China helps Tajikistan tackle grassland degradation       » Immuno-oncology trials in China surge more than 50 per cent       » Yeast for industrial biotechnology       » Uncontrolled hypertension in rural communities      
BIOBOARD - INSIDE INDUSTRY
Danziger Innovations and Precision BioSciences collaborate on genome modification in ornamental plants
Danziger Innovations and Precision BioSciences have successfully generated site-specific genome modifications in petunia and jasmine tobacco by combining Precision's Directed Nuclease Editor (DNE) gene editing technolgy with Danziger's MemoGene gene delivery system. This successful research effort was aimed at genetic control of flower color but researchers at Precision and Danziger believe that the approach can be used more broadly to address genome engineering challenges in plants that are recalcitrant to existing transformation methods without requiring the insertion of foreign DNA into the plant genome.

Danziger Innovations is an Israeli biotechnology company engaged in the discovery and manufacture of new advanced breeding solutions to improve traits in crops for the world agricultural community's needs. Precision BioSciences is a biotechnology company focused on developing and commercializing therapeutics and services based on its ability to enable site-specific genome modifications within a living organism.

"While DNE has a long and successful history in major row crops, we see a significant commercial opportunity in ornamentals and other high-value plants"

Precision's DNE technology is a proprietary method for making site-specific modifications to complex genomes. The current version of the technology can create virtually any desired genetic change without the high-levels of off-target modification that are often seen with alternative genome engineering methods.

Danziger's MemoGene technology is a proprietary, viral-based technology for precise gene modifications, using highly innovative tools to deliver endonucleases to specific compartments in the plant cell by uniquely designed viral vectors. The MemoGene solution bypasses current biotechnological barriers and offers two main consumer applications: Deletion and Insertion/Substitution of DNA sequences to create new, commercially desirable "tailor-made" varieties of field, vegetable, woody and ornamental crops.

"While DNE has a long and successful history in major row crops, we see a significant commercial opportunity in ornamentals and other high-value plants," said Derek Jantz, Precision's VP of Scientific Development. "MemoGene will allow us to work in numerous such species that do not have established transformation protocols and potentially reduce regulatory burdens."

"We are very pleased with this cooperation. Using the MemoGene and DNE technologies together creates a synergy that shall lead to the creation of new and improved varieties, with novel traits," said Micha Danziger, CEO of Danziger Innovations. "Using our MemoGene Deletion technology allows us to create a mutated plant, without leaving any trace of foreign DNA in plant genome. We may achieve the predictable results at reduced time and cost."

Source: Business Wire

Click here for the complete issue.

NEWS CRUNCH  
news Shire, Microsoft and EURORDIS form Global Commission to accelerate time to diagnosis for children with rare diseases
news EmTech Asia explores future of life, humanity and economy
news Biology of Ageing II - Impactful Interventions
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  
COLUMNS  
Click here to receive APBN e-newsletters once a month!

APBN Editorial Calendar 2018
January:
Obesity / Outlook for 2018
February:
Searching for the fountain of youth
March:
Women in Science - Making a difference
April:
Digestive health in the 21st century - Trust your guts
May:
Dental health - The root to good health
June:
Cancer - Therapies and strategies for better patient outcomes
July:
Water management / Vaccination
August:
Regenerative medicine / Biotech start ups
September:
Digital healthcare / 3D printing
October:
Bones / Breast cancer
November:
Liver health / Top science research nations & institutions
December:
AIDS / Breakthrough of the year/Emerging trends
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2018 World Scientific Publishing Co Pte Ltd  •  Privacy Policy